NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software. NeurAxis Inc. will begin...

Current constipation medications don't provide relief for some patients with Chronic Idiopathic Constipation, per Gastroenterologist survey BOSTON, April 09, 2024 (GLOBE NEWSWIRE) -- Millions of Americans currently receiving treatment for chronic constipation may not be seeing the relief they hope for, a recent tele-study by Vibrant...

TIME Honors Vibrant’s Chronic Constipation Treatment Among 2023’s Best Inventions BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- TIME has honored Vibrant, the groundbreaking drug-free treatment for chronic constipation by Vibrant Gastro, as part of its list of 2023’s Best...